《中华人民共和国药典》(2020年版)中药材和中药饮片质量标准增修订工作思路 |
投稿时间:2018-11-14 点此下载全文
|
引用本文:屠鹏飞,黄璐琦,陈万生,陈士林,曹晖,李振国,钱忠直.《中华人民共和国药典》(2020年版)中药材和中药饮片质量标准增修订工作思路[J].中国现代中药,2018,20(12):1459-1464 |
DOI: |
摘要点击次数: 1293 |
全文下载次数: 520 |
|
基金项目:国家重点研发计划(2018YFC1707300) |
|
中文摘要:《中华人民共和国药典》(《中国药典》)是在中国境内生产、销售和使用药品必须执行的标准,《中国药典》每5年的增修订已成为药品生产和销售企业、医疗机构、科研单位等关注的热点。中药材是生产中药饮片的原料,中药饮片是临床汤剂和中成药生产的原料,是保障中医临床用药和中药产业健康发展的基础。本文系统介绍《中国药典》2020年版中药材和中药饮片质量标准增修订的思路,并对业界和社会关注的有关中药材和中药饮片质量标准问题进行讨论,以供参考。 |
中文关键词:中华人民共和国药典 质量标准 中药材 中药饮片 中药 |
|
Working Ideas on Amendment of Quality Standards of Chinese Crude Drugs and Decoction Pieces in Chinese Pharmacopoeia(2020 Edition) |
|
|
Abstract:Chinese Pharmacopoeia is a criterion that must be implemented for the drug production,sale,and application in China,and its amendment of every five years has become the focus for pharmaceutical production and sales companies,medical institutions,and research institutes.Chinese crude drugs and decoction pieces,as the raw materials for producing the clinical decoctions and proprietary Chinese medicines,are the basis of the healthy development of traditional Chinese medicine clinical medication and Chinese medicine industry.This article systematically introduces the working ideas on the amendment of the quality standards of Chinese crude drugs and decoction pieces in the Chinese Pharmacopoeia(2020 Edition)and discusses the issues referring to the quality standards which are of great concern to the industry and the society. |
keywords:Chinese Pharmacopoeia Quality standards Chinese crude drugs Decoction pieces traditional Chinese medicines |
查看全文
查看/发表评论 下载PDF阅读器 |